Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.
May 20, 2021 07:30 ET
|
Field Trip Health, Ltd.
TORONTO, May 20, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey
May 18, 2021 07:30 ET
|
Field Trip Health, Ltd.
The survey conducted by YouGov Plc found that: More than 8 in 10 Americans report showing symptoms of depressionMany are turning to different substances and vices to copeWomen are bearing the brunt...
Field Trip Health Ltd. Announces DTC Eligibility
May 06, 2021 09:10 ET
|
Field Trip Health, Ltd.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers
May 04, 2021 07:30 ET
|
Field Trip Health, Ltd.
HOUSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing
March 17, 2021 09:10 ET
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT;...
Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering
February 26, 2021 10:17 ET
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX:...
Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares
February 25, 2021 15:20 ET
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT;...
Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results
February 16, 2021 17:30 ET
|
Field Trip Health, Ltd.
Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter Field Trip continues to advance development of FT-104, a novel psychedelic molecule with pending...
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET
February 10, 2021 07:55 ET
|
Field Trip Health, Ltd.
TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, FTRP.WT, OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica
February 09, 2021 07:30 ET
|
Field Trip Health, Ltd.
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...